Status:
COMPLETED
Effect of Ketamine in Depressive Symptoms of Elderly Patients With Visual Impairment.
Lead Sponsor:
Instituto Mexicano del Seguro Social
Collaborating Sponsors:
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado
Conditions:
Depression in Old Age
Ketamine
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
the prevalence of depression in elderly is from 4 to 30% and is associated with a lower quality of life mayor medical comorbidity, and increased mortality. Although there are various treatments for de...
Detailed Description
The final objective of the present study is to report the effects of a single infusion of 0.5 mg / kg ketamine in infusion on depressive symptoms assessed using the scale Yesavage's abbreviated Geriat...
Eligibility Criteria
Inclusion
- Men and women aged 60 years or older who due to the severity of visual disability required to be operated on for eye surgery using retrobulbar block
- Intraocular pressure \<20 mm Hg and
- ASA functional capacity from I to III
Exclusion
- Previous antidepressants medications
- Cognitive impairment was found according to the Short Portable Mental Status Questionnaire (SPMSQ) assessment
- In case of a history of psychosis, schizophrenia, nephropathy
- They had a history of difficulties to control arterial blood pressure, uncontrolled hepatic disorders or had a history of adverse response to ketamine according clinical records
Key Trial Info
Start Date :
April 15 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 30 2018
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03473431
Start Date
April 15 2018
End Date
July 30 2018
Last Update
February 28 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro Medico Nacional Siglo XXI. UMAE Hospital de Especialidades
Mexico City, Mexico City, Mexico, 06720